The Study on the expression of SOCS-1/3 in the peripheral blood mononuclear cells in patients with systemic inflammatory response syndrome
10.3760/cma.j.issn.1008-6706.2010.01.002
- VernacularTitle:全身炎症反应综合征患者外周血单个核细胞细胞因子信号转导抑制因子-1/3的表达
- Author:
Yangbing LIANG
;
Hao TANG
;
Zhibin CHEN
;
Zhenyu LI
;
Jia XU
;
Yunsheng YUAN
;
Zhongfu MA
- Publication Type:Journal Article
- Keywords:
Systemic inflammatory response syndrome;
Cytokine;
suppressor of cytokines signaling protein
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(1):4-6,插5
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the mRNA and protein expression of SOCS-1 and SOCS-3 in the peripheral blood mononuclear cells(PBMCs) in patients with systemic inflammatory response syndrome(SIRS) and explore its clinical significance.Methods Peripheral blood of 20 patients with SIRS and 16 healthy people wag collected and the PBMCs were isolated by centrifugafion and Ficoll-Hypaque sedimentation.The mRNA of SOCS-1 and SOCS-3 was determined by reverse transcription-polymerase chain reaction(RT-PCR).And the protein content of SOCS-1 and SOCS-3 was determined by Western Blotting.Results The SOCS-1 mRNA expression in the PBMCs of SIRS group (0.642±0.112) was significant higher than that of control group(0.458±0.044)(P<0.05).There was no significant difference between the PBMCs,SOCS-1 content of control group(0.488±0.019) and SIRS group (0.471±0.041).The SOCS-3 mRNA expression in the PBMCs of SIRS group(0.989±0.324) was higher than that control group(0.459±0.046)(P<0.05).There was no significant difference between the PBMCs'SOCS-3 content of control group(0.400±0.025) and SIRS group(0.426±0.015).Conclusions The mRNA expression of SOCS-1 and SOCS-3 in the PBMCs were higher in SIRS patients.The SOCS-1 and SOCS-3 may participate in the development of SIRS.
